Aelis Farma (France) Buy Hold or Sell Recommendation
| AELIS Stock | 2.08 0.12 5.45% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Aelis Farma SA is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell Aelis Farma SA within the specified time frame.
Check out Aelis Farma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Aelis and provide practical buy, sell, or hold advice based on investors' constraints. Aelis Farma SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Aelis |
Execute Aelis Farma Buy or Sell Advice
The Aelis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Aelis Farma SA. Macroaxis does not own or have any residual interests in Aelis Farma SA or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Aelis Farma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Aelis Farma Trading Alerts and Improvement Suggestions
| Aelis Farma SA generated a negative expected return over the last 90 days | |
| Aelis Farma SA has high historical volatility and very poor performance |
Aelis Farma Returns Distribution Density
The distribution of Aelis Farma's historical returns is an attempt to chart the uncertainty of Aelis Farma's future price movements. The chart of the probability distribution of Aelis Farma daily returns describes the distribution of returns around its average expected value. We use Aelis Farma SA price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Aelis Farma returns is essential to provide solid investment advice for Aelis Farma.
| Mean Return | -1.06 | Value At Risk | -7.23 | Potential Upside | 3.33 | Standard Deviation | 3.46 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Aelis Farma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Aelis Farma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Aelis Farma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Aelis Farma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Aelis stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -1.05 | |
β | Beta against Dow Jones | -0.2 | |
σ | Overall volatility | 3.20 | |
Ir | Information ratio | -0.34 |
Aelis Farma Volatility Alert
Aelis Farma SA exhibits very low volatility with skewness of 0.02 and kurtosis of 1.05. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Aelis Farma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Aelis Farma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Aelis Farma Fundamentals Vs Peers
Comparing Aelis Farma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Aelis Farma's direct or indirect competition across all of the common fundamentals between Aelis Farma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Aelis Farma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Aelis Farma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Aelis Farma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Aelis Farma to competition |
| Fundamentals | Aelis Farma | Peer Average |
| Return On Equity | -1.0 | -0.31 |
| Return On Asset | -0.11 | -0.14 |
| Profit Margin | (2.04) % | (1.27) % |
| Operating Margin | (1.01) % | (5.51) % |
| Current Valuation | 102.61 M | 16.62 B |
| Shares Outstanding | 12.5 M | 571.82 M |
| Shares Owned By Institutions | 0.20 % | 39.21 % |
| Price To Book | 5.85 X | 9.51 X |
| Price To Sales | 21.46 X | 11.42 X |
| Revenue | 9.07 M | 9.43 B |
| Gross Profit | 10.76 M | 27.38 B |
| EBITDA | (6.7 M) | 3.9 B |
| Net Income | 574 K | 570.98 M |
| Cash And Equivalents | 24.71 M | 2.7 B |
| Total Debt | 3.26 M | 5.32 B |
| Book Value Per Share | 1.91 X | 1.93 K |
| Cash Flow From Operations | 18.97 M | 971.22 M |
| Earnings Per Share | 0.32 X | 3.12 X |
| Target Price | 21.5 | |
| Number Of Employees | 22 | 18.84 K |
| Market Capitalization | 177.77 M | 19.03 B |
| Total Asset | 28.31 M | 29.47 B |
| Z Score | 32.4 | 8.72 |
| Net Asset | 28.31 M |
Aelis Farma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Aelis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Aelis Farma Buy or Sell Advice
When is the right time to buy or sell Aelis Farma SA? Buying financial instruments such as Aelis Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Aelis Farma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Developed Markets Basket ETFs Thematic Idea Now
Developed Markets Basket ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Developed Markets Basket ETFs theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Developed Markets Basket ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Aelis Stock Analysis
When running Aelis Farma's price analysis, check to measure Aelis Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aelis Farma is operating at the current time. Most of Aelis Farma's value examination focuses on studying past and present price action to predict the probability of Aelis Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aelis Farma's price. Additionally, you may evaluate how the addition of Aelis Farma to your portfolios can decrease your overall portfolio volatility.